Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enzyme-inducing sulfenate and thiosulfinate esters described by U.S. university

July 6, 2001

WHI-P154 claimed for sensitizing cancer cells to radiation

July 6, 2001

Several series of antineoplastic agents presented by ADIR in patents

July 6, 2001

FDA grants approval for Debiopharm's Trelstar LA for use in advanced prostate cancer

July 6, 2001

Wyeth-Ayerst and Taxolog to develop novel taxanes

July 6, 2001

Peregrine's TNT treatment shows positive results in phase I/II trial

July 5, 2001

Bradykinin B2 antagonists with anticancer activity

July 5, 2001

AEterna's Neovastat demonstrates safety and dose-related activity in prostate cancer trial

July 5, 2001

Cytovia presents new series of caspase activators and apoptosis inducers

July 4, 2001

Nippon Shinyaku to market and distribute DepoCyt in Japan

July 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...